Agnieszka Jarzynka-Graczyk

Nielubowicza 5 Street
Warsaw, MZ 02097, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Journal: Leukemia
Published: March 11, 2026

The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

Journal: FEBS letters
Published: March 07, 2026

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Journal: bioRxiv : the preprint server for biology
Published: March 17, 2025

Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies.

Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies.

Journal: Biochimica et biophysica acta. Reviews on cancer
Published: November 08, 2024

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

Journal: Oncoimmunology
Published: June 07, 2024

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin.

Journal: Cancer research
Published: March 04, 2024

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Journal: The Journal of biological chemistry
Published: November 17, 2022

PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.

PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.

Journal: Journal for immunotherapy of cancer
Published: December 19, 2021

The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.

The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.

Journal: Cancers
Published: November 03, 2021

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies.

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies.

Journal: Cancer research
Published: April 01, 2021

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.

Journal: Oncogene
Published: February 03, 2021

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Journal: Cancer immunology research
Published: December 23, 2020
Showing 1-12 of 30

Last Updated: 09/26/2026